Impact BioMedical, Inc. (IBO)
4.16
+0.14
(+3.48%)
USD |
NYAM |
Nov 04, 16:00
4.16
0.00 (0.00%)
After-Hours: 18:49
Impact BioMedical Total Return Price : 4.16 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 4.02 |
| November 02, 2026 | 4.01 |
| October 30, 2026 | 3.80 |
| October 29, 2026 | 3.87 |
| October 28, 2026 | 3.990 |
| October 27, 2026 | 3.55 |
| October 26, 2026 | 3.73 |
| October 23, 2026 | 3.60 |
| October 22, 2026 | 3.80 |
| October 21, 2026 | 4.02 |
| October 20, 2026 | 3.268 |
| October 19, 2026 | 3.06 |
| October 16, 2026 | 2.68 |
| October 15, 2026 | 3.158 |
| October 14, 2026 | 3.403 |
| October 13, 2026 | 3.98 |
| October 12, 2026 | 4.03 |
| October 09, 2026 | 4.25 |
| October 08, 2026 | 4.11 |
| October 07, 2026 | 4.48 |
| October 06, 2026 | 4.68 |
| October 05, 2026 | 4.84 |
| October 02, 2026 | 5.320 |
| October 01, 2026 | 5.43 |
| September 30, 2026 | 5.60 |
| Date | Value |
|---|---|
| September 29, 2026 | 5.60 |
| September 28, 2026 | 5.61 |
| September 25, 2026 | 5.69 |
| September 24, 2026 | 5.65 |
| September 23, 2026 | 6.63 |
| September 22, 2026 | 6.658 |
| September 21, 2026 | 7.013 |
| September 18, 2026 | 7.446 |
| September 17, 2026 | 7.211 |
| September 16, 2026 | 6.285 |
| September 15, 2026 | 6.676 |
| September 14, 2026 | 6.109 |
| September 11, 2026 | 5.808 |
| September 10, 2026 | 5.565 |
| September 09, 2026 | 6.230 |
| September 08, 2026 | 6.31 |
| September 04, 2026 | 6.815 |
| September 03, 2026 | 6.058 |
| September 02, 2026 | 6.184 |
| September 01, 2026 | 5.78 |
| August 31, 2026 | 5.820 |
| August 28, 2026 | 5.600 |
| August 27, 2026 | 5.565 |
| August 26, 2026 | 5.554 |
| August 25, 2026 | 5.808 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| LENZ Therapeutics, Inc. | 3.47 |
| Enveric Biosciences, Inc. | 1.47 |
| ANI Pharmaceuticals, Inc. | 71.68 |
| Corcept Therapeutics, Inc. | 79.20 |
| Veru, Inc. | 2.20 |